Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
30273709
DOI
10.1016/j.jaci.2018.08.049
PII: S0091-6749(18)31359-9
Knihovny.cz E-zdroje
- Klíčová slova
- Allergic Rhinitis and Its Impact on Asthma, Change management, asthma, rhinitis,
- MeSH
- alergická rýma * diagnóza terapie MeSH
- bronchiální astma * diagnóza terapie MeSH
- chorobopisy MeSH
- lidé MeSH
- multimorbidita * MeSH
- řízení změn MeSH
- telemedicína * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.
Allergist in private practice La Rochelle France
Allergist in private practice Reims France
Allergy and Respiratory Research Group University of Edinburgh Edinburgh United Kingdom
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Association of Finnish Pharmacies Helsinki Finland
Center for Rhinology and Allergology Wiesbaden Germany
Centre for Clinical Research Sörmland Uppsala University Eskilstuna Sweden
Children's Hospital Srebrnjak Zagreb School of Medicine University J J Strossmayer Osijek Croatia
CIRFF Federico 2 University Naples Italy
Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon South Korea
Department of Allergy and Immunology Hospital Quirón Bizkaia Erandio Spain
Department of ENT Medical University of Graz Graz Austria
Department of Medicine Clinical Immunology and Allergy McMaster University Hamilton Ontario Canada
Department of Medicine University of Cape Town Cape Town South Africa
Department of Nephrology and Endocrinology Karolinska University Hospital Stockholm Sweden
Department of Otolaryngology Nippon Medical School Tokyo Japan
Department of Otorhinolaryngology Academic Medical Centres AMC Amsterdam The Netherlands
Department of Otorhinolaryngology Chiba University Hospital Chiba Japan
Department of Otorhinolaryngology Universitätsklinikum Düsseldorf Dusseldorf Germany
Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Pharmacy of University of Naples Federico 2 Naples Italy
Department of Public Health and Primary Care Leiden University Medical Center
Department of Pulmonary Medicine Rashid Hospital Dubai United Arab Emirates
Department of Pulmonology Celal Bayar University Manisa Turkey
DG for Health and Social Care Scottish Government Edinburgh United Kingdom
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy Immunology University of South Florida Tampa Fla
European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
Faculty of Medicine Vilnius University Vilnius Lithuania
Farmacias Holon Lisbon Portugal
Immunology and Allergy Division Clinical Hospital University of Chile Santiago Chile
iQ4U Consultants London United Kingdom
ISGlobal Centre for Research in Environmental Epidemiology Barcelona Spain
Johns Hopkins School of Medicine Baltimore Md
Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
MACVIA France Fondation partenariale FMC VIA LR Montpellier France
Medical Consulting Czarlewski Levallois France
National Hospital Organization Tokyo National Hospital Tokyo Japan
Nova Southeastern University Fort Lauderdale Fla
Pediatric Allergy and Asthma Unit Hacettepe University School of Medicine Ankara Turkey
Pediatric Allergy and Immunology Unit Children's hospital Ain Shams University Cairo Egypt
Scientific Centre of Children's Health under the MoH Moscow Russian Federation
Section of Allergy and Immunology Saint Louis University School of Medicine St Louis Mo
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Sidkkids hospitala and Institute of Health Policy Management and Evaluation Toronto Ontario Canada
Skin and Allergy Hospital Helsinki University Hospital and University of Helsinki Helsinki Finland
Sociedad Paraguaya de Alergia Asma e Inmunologı'a Asuncion
SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
Transylvania University Brasov Brasov Romania
Ukrainina Medical Stomatological Academy Poltava Ukraine
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia
University Hospital Sv Ivan Rilski Sofia Bulgaria
University of Bari Medical School Unit of Geriatric Immunoallergology Bari Italy
University of Medicine and Pharmacy Hochiminh City Vietnam
Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
Citace poskytuje Crossref.org
Helsinki by nature: The Nature Step to Respiratory Health
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases